Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gerd Wegener

Showing results (1-10 of 26) with videos related to

Pageof 3
Sort By:
Anticancer Research|July 26, 2007
Definitive conformal radiotherapy for localized high-risk prostate cancer: a long-term follow-up study with PSA courseFrank Bruns, Cordula Franzki, Gerd Wegener, et al.
Anticancer Research|July 15, 2009
Definitive conformal radiotherapy for localized prostate cancer: a long-term follow-up studyCordula M C Deichmueller, Gerd Wegener, Johann H Karstens, et al.
Head & Neck Oncology|June 1, 2012
Squamous cell carcinoma of the oral cavity and the oropharynx in patients less than 40 years of age: a 20-year analysisSamuel E Udeabor, Majeed Rana, Gerd Wegener, et al.
BMC Cancer|March 19, 2013
Preoperative serum C- reactive protein: a prognostic marker in patients with upper urinary tract urothelial carcinomaBarbara Stein, Andres Jan Schrader, Gerd Wegener, et al.
Medical Oncology (Northwood, London, England)|September 6, 2013
Serum C-reactive protein: a prognostic factor in metastatic urothelial cancer of the bladderHendrik Eggers, Christoph Seidel, Andres Jan Schrader, et al.
In Vivo (Athens, Greece)|September 9, 2017
Impact of Time Factors on Outcome in Patients with Head and Neck Cancer Treated with Definitive Radio(Chemo)TherapySören Dahlke, Diana Steinmann, Hans Christiansen, et al.
Head & Neck Oncology|February 25, 2011
Prognostic significance of heat shock protein 70 (HSP70) in patients with oral cancerFrank Tavassol, Oliver F Starke, Horst Kokemüller, et al.
Springerplus|July 16, 2013
Incidence of synchronous and metachronous adrenal metastases following tumor nephrectomy in renal cell cancer patients: a retrospective bi-center analysisInga Peters, Milan Hora, Thomas R Herrmann, et al.
BMC Cancer|September 11, 2012
Validation of CRP as prognostic marker for renal cell carcinoma in a large series of patientsSandra Steffens, Astrid Köhler, Raphael Rudolph, et al.
European Urology|October 30, 2010
Is there a need to further subclassify pT2 renal cell cancers as implemented by the revised 7th TNM version?Sandra Waalkes, Frank Becker, Andres J Schrader, et al.
Pageof 3

Showing results (1-10 of 26) with videos related to

Sort By:
Pageof 3
Anticancer Research|July 26, 2007
Definitive conformal radiotherapy for localized high-risk prostate cancer: a long-term follow-up study with PSA courseFrank Bruns, Cordula Franzki, Gerd Wegener, et al.
Anticancer Research|July 15, 2009
Definitive conformal radiotherapy for localized prostate cancer: a long-term follow-up studyCordula M C Deichmueller, Gerd Wegener, Johann H Karstens, et al.
Head & Neck Oncology|June 1, 2012
Squamous cell carcinoma of the oral cavity and the oropharynx in patients less than 40 years of age: a 20-year analysisSamuel E Udeabor, Majeed Rana, Gerd Wegener, et al.
BMC Cancer|March 19, 2013
Preoperative serum C- reactive protein: a prognostic marker in patients with upper urinary tract urothelial carcinomaBarbara Stein, Andres Jan Schrader, Gerd Wegener, et al.
Medical Oncology (Northwood, London, England)|September 6, 2013
Serum C-reactive protein: a prognostic factor in metastatic urothelial cancer of the bladderHendrik Eggers, Christoph Seidel, Andres Jan Schrader, et al.
In Vivo (Athens, Greece)|September 9, 2017
Impact of Time Factors on Outcome in Patients with Head and Neck Cancer Treated with Definitive Radio(Chemo)TherapySören Dahlke, Diana Steinmann, Hans Christiansen, et al.
Head & Neck Oncology|February 25, 2011
Prognostic significance of heat shock protein 70 (HSP70) in patients with oral cancerFrank Tavassol, Oliver F Starke, Horst Kokemüller, et al.
Springerplus|July 16, 2013
Incidence of synchronous and metachronous adrenal metastases following tumor nephrectomy in renal cell cancer patients: a retrospective bi-center analysisInga Peters, Milan Hora, Thomas R Herrmann, et al.
BMC Cancer|September 11, 2012
Validation of CRP as prognostic marker for renal cell carcinoma in a large series of patientsSandra Steffens, Astrid Köhler, Raphael Rudolph, et al.
European Urology|October 30, 2010
Is there a need to further subclassify pT2 renal cell cancers as implemented by the revised 7th TNM version?Sandra Waalkes, Frank Becker, Andres J Schrader, et al.
Pageof 3